Showing results (31-40 of 174) with videos related to
Sort By:
Pageof 18
Therapeutic Advances in Medical Oncology|December 22, 2018
Managing advanced HR-positive, HER2-negative breast cancer with CDK4/6 inhibitors in post-menopausal patients: is there a best sequence?Lorenzo Rossi, Amelia McCartney, Emanuela Risi, et al.Critical Reviews in Oncology/Hematology|September 3, 2008
Taxanes in the elderly: can we gain as much and be less toxic?Laura Biganzoli, Sara Licitra, Erica Moretti, et al.European Journal of Cancer (Oxford, England : 1990)|November 11, 2008
Topoisomerase II alpha as a marker predicting anthracyclines' activity in early breast cancer patients: ready for the primetime?Angelo Di Leo, Laura Biganzoli, Wederson Claudino, et al.Nature Reviews. Clinical Oncology|May 27, 2015
Challenges in the management of advanced, ER-positive, HER2-negative breast cancerChristopher D Hart, Ilenia Migliaccio, Luca Malorni, et al.Cancers|March 28, 2014
Can biomarker assessment on circulating tumor cells help direct therapy in metastatic breast cancer?Natalie Turner, Marta Pestrin, Francesca Galardi, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 18, 2008
Special focus on cardiac toxicity of different sequences of adjuvant doxorubicin/docetaxel/CMF regimens combined with radiotherapy in breast cancer patientsNicolas Magné, Pierre Castadot, Cyrus Chargari, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2007
Metabolomics: available results, current research projects in breast cancer, and future applicationsWederson Marcos Claudino, Alessandro Quattrone, Laura Biganzoli, et al.Tumori|June 15, 2007
Gastric cancer metastatic to the pituitary gland: a case reportDaniele Pozzessere, Elena Zafarana, Anna Maria Buccoliero, et al.Breast (Edinburgh, Scotland)|July 6, 2017
De-escalating and escalating treatment beyond endocrine therapy in patients with luminal breast cancerAmelia McCartney, Alessia Vignoli, Christopher Hart, et al.Cancer Treatment Reviews|May 19, 2018
Metabolomics in breast cancer: A decade in reviewAmelia McCartney, Alessia Vignoli, Laura Biganzoli, et al.Pageof 18